Ahmed A. Suleiman
University of Anbar(IQ)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Chronic Lymphocytic Leukemia Research, Inflammatory Bowel Disease, Lung Cancer Treatments and Mutations, Microscopic Colitis
Most-Cited Works
- → Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency(2010)102 cited
- → Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study(2020)38 cited
- → A Semiphysiological Population Pharmacokinetic Model for Dynamic Inhibition of Liver and Gut Wall Cytochrome P450 3A by Voriconazole(2013)37 cited
- → Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I–III Clinical Trials(2019)35 cited
- → Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials(2018)32 cited
- → Modelling and Simulation of the Positive and Negative Syndrome Scale (PANSS) Time Course and Dropout Hazard in Placebo Arms of Schizophrenia Clinical Trials(2012)31 cited
- → Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis(2019)29 cited
- → Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients(2019)29 cited
- → Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment(2016)29 cited
- → Pharmacokinetic–pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: The use of PANSS total score and clinical utility(2013)28 cited